Bioinfra Overview

Founded 2001
Status Private
Latest Deal Type 2ndary - Private

Bioinfra General Information


Provider of cancer screening treatment designed for early cancer diagnostics. The company's cancer screening treatment specializes in detecting cancer and chronic disease through blood analysis, provides early cancer detection service based on over 7.2K validated cancer sample and has created a diagnostic algorithm that uses bioinformatics and have established 6 cancer score model.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare
Primary Office
  • Daehak-ro 49, 7F
  • Jongno-gu
  • Seoul, 03127
  • South Korea
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioinfra Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Jan-2016 Completed Generating Revenue
2. Grant 01-Jan-2015 0000 Completed Generating Revenue
1. Early Stage VC Completed Startup

Bioinfra Executive Team (1)

Name Title Board Seat Contact Info
Chul-Woo Kim Founder, Vice President & Chief Executive Officer

Bioinfra Investments (1)

To view Bioinfra‘s complete investment and acquisition history, request access »
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 00000000000 02-Nov-2018 00000 00000 00 000.00 Biotechnology

Ready to get started?

Request a free trial